653 related articles for article (PubMed ID: 25433793)
21. Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions.
Arnold DT; Hamilton FW; Elvers KT; Frankland SW; Zahan-Evans N; Patole S; Medford A; Bhatnagar R; Maskell NA
Am J Respir Crit Care Med; 2020 Jun; 201(12):1545-1553. PubMed ID: 32069085
[No Abstract] [Full Text] [Related]
22. Validity of procalcitonin and C-reactive protein measurement when differentiating between benign and malignant pleural effusion.
Botana-Rial M; Casado-Rey P; Leiro-Fernández V; Andrade-Olivié M; Represas-Represas C; Fernández-Villar A
Clin Lab; 2011; 57(5-6):373-8. PubMed ID: 21755828
[TBL] [Abstract][Full Text] [Related]
23. [From pneumonic infiltration to parapneumonic effusion--from effusion to pleural empyema: internal medicine aspects of parapneumonic effusion development and pleural empyema].
Domej W; Wenisch C; Demel U; Tilz GP
Wien Med Wochenschr; 2003; 153(15-16):349-53. PubMed ID: 13677257
[TBL] [Abstract][Full Text] [Related]
24. Atypical Pleural Fluid Profiles in Tuberculous Pleural Effusion: Sequential Changes Compared with Parapneumonic and Malignant Pleural Effusions.
Kim CH; Lee SY; Lee YD; Yoo SS; Lee SY; Cha SI; Park JY; Lee J
Intern Med; 2016; 55(13):1713-9. PubMed ID: 27374670
[TBL] [Abstract][Full Text] [Related]
25. The implication of elevated carcinoembryonic antigen level in pleural fluid of patients with non-malignant pleural effusion.
Ryu JS; Lee HJ; Cho JH; Han HS; Lee HL
Respirology; 2003 Dec; 8(4):487-91. PubMed ID: 14629653
[TBL] [Abstract][Full Text] [Related]
26. Value of adenosine deaminase in the diagnosis of tuberculous pleural effusions in young patients in a region of high prevalence of tuberculosis.
Valdés L; Alvarez D; San José E; Juanatey JR; Pose A; Valle JM; Salgueiro M; Suárez JR
Thorax; 1995 Jun; 50(6):600-3. PubMed ID: 7638798
[TBL] [Abstract][Full Text] [Related]
27. CT appearance of parapneumonic effusions in children: findings are not specific for empyema.
Donnelly LF; Klosterman LA
AJR Am J Roentgenol; 1997 Jul; 169(1):179-82. PubMed ID: 9207521
[TBL] [Abstract][Full Text] [Related]
28. Elevated pleural fluid levels of defensins in patients with empyema.
Ashitani J; Mukae H; Nakazato M; Taniguchi H; Ogawa K; Kohno S; Matsukura S
Chest; 1998 Mar; 113(3):788-94. PubMed ID: 9515858
[TBL] [Abstract][Full Text] [Related]
29. Recommendations of diagnosis and treatment of pleural effusion. Update.
Villena Garrido V; Cases Viedma E; Fernández Villar A; de Pablo Gafas A; Pérez Rodríguez E; Porcel Pérez JM; Rodríguez Panadero F; Ruiz Martínez C; Salvatierra Velázquez A; Valdés Cuadrado L
Arch Bronconeumol; 2014 Jun; 50(6):235-49. PubMed ID: 24698396
[TBL] [Abstract][Full Text] [Related]
30. [Role of C-C chemokines in the determination of pleural effusion etiology].
Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
Pneumonol Alergol Pol; 2008; 76(6):415-20. PubMed ID: 19173189
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic performance of different pleural fluid biomarkers in tuberculous pleurisy.
Klimiuk J; Krenke R; Safianowska A; Korczynski P; Chazan R
Adv Exp Med Biol; 2015; 852():21-30. PubMed ID: 25523627
[TBL] [Abstract][Full Text] [Related]
32. Determination of adenosine deaminase activity and its isoenzymes for diagnosis of pleural effusions.
Gorguner M; Cerci M; Gorguner I
Respirology; 2000 Dec; 5(4):321-4. PubMed ID: 11192541
[TBL] [Abstract][Full Text] [Related]
33. Pleural effusions caused by infection.
Varkey B
Postgrad Med; 1986 Oct; 80(5):213-6, 219, 222-3. PubMed ID: 3763525
[TBL] [Abstract][Full Text] [Related]
34. Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions.
Alemán C; Manuel Porcel J; Ma Segura R; Alegre J; Esquerda A; Ruiz E; Bielsa S; de Sevilla TF
Med Clin (Barc); 2009 Oct; 133(12):449-53. PubMed ID: 19783262
[TBL] [Abstract][Full Text] [Related]
35. A retrospective study on the combined biomarkers and ratios in serum and pleural fluid to distinguish the multiple types of pleural effusion.
Lin L; Li S; Xiong Q; Wang H
BMC Pulm Med; 2021 Mar; 21(1):95. PubMed ID: 33740937
[TBL] [Abstract][Full Text] [Related]
36. The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions.
Watanabe N; Ishii T; Kita N; Kanaji N; Nakamura H; Nanki N; Ueda Y; Tojo Y; Kadowaki N; Bandoh S
BMC Pulm Med; 2018 Nov; 18(1):176. PubMed ID: 30470216
[TBL] [Abstract][Full Text] [Related]
37. Predicting malignant and tuberculous pleural effusions through demographics and pleural fluid analysis of patients.
Valdés L; San-José E; Ferreiro L; Golpe A; González-Barcala FJ; Toubes ME; Rodríguez-Álvarez MX; Álvarez-Dobaño JM; Rodríguez-Núñez N; Rábade C; Gude F
Clin Respir J; 2015 Apr; 9(2):203-13. PubMed ID: 25849297
[TBL] [Abstract][Full Text] [Related]
38. Development and Validation of the COMPLES Score for Differentiating Between Tuberculous Effusions with Low Pleural pH or Glucose and Complicated Parapneumonic Effusions.
Corral-Gudino L; García-Zamalloa A; Prada-González C; Bielsa S; Alexis D; Taboada-Gómez J; Dos-Santos-Gallego PR; Alonso-Fernández MA; Porcel JM
Lung; 2016 Oct; 194(5):847-54. PubMed ID: 27401009
[TBL] [Abstract][Full Text] [Related]
39. Metabonomics by proton nuclear magnetic resonance in human pleural effusions: A route to discriminate between benign and malignant pleural effusions and to target small molecules as potential cancer biomarkers.
Zennaro L; Vanzani P; Nicolè L; Cappellesso R; Fassina A
Cancer Cytopathol; 2017 May; 125(5):341-348. PubMed ID: 28140518
[TBL] [Abstract][Full Text] [Related]
40. The diagnosis of pleural effusions.
Porcel JM; Azzopardi M; Koegelenberg CF; Maldonado F; Rahman NM; Lee YC
Expert Rev Respir Med; 2015; 9(6):801-15. PubMed ID: 26449328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
